Cel
Leukemias are a challenge to society and a cost factor because of their frequency in all age groups. They also serve as a model for a variety of diseases and possess exemplary relevance for basic research and patient care. Leukemia research and therapy have achieved high standards and even a leading position in several European countries with regard to clinical trials, standardization of diagnostics and molecular studies of signal transduction and gene expression. A true European world leadership, however, has not been accomplished yet due to national fragmentation of leukemia trial groups, diagnostic approaches and treatment research activities and a need for central information and communication structures.
The objective is to integrate the leading leukemia trial groups (CML, AML, ALL, CLL, MDS, CMPD), their interdisciplinary partners (diagnostics, treatment research, registry, guidelines), industry and SMEs across Europe to form a cooperative network for advancements in leukemia-related research and health care.Integration will be supported by central information, communication, education and management structures. Other goals are to intensify target and drug discovery, to shorten the time period to clinical translation, to apply advanced genomics, telematics and biotechnology to therapeutic progress and to promote research relevant also for solid cancers by large clinical trials. Furthermore, metaanalyses of specific subaspects, elaboration of prognostic scores, recognition of gender specific differences, creation of uniform data sets for trials and registration, introduction of standards for diagnostics and treatment and development of evidence-based guidelines will be promoted throughout Europe. The proposed network will have the expertise and critical mass for European added value and world leadership. It will structure European research durably, spread European scientific excellence in the field of leukemias and can start immediately.
Dziedzina nauki
Słowa kluczowe
Zaproszenie do składania wniosków
FP6-2002-LIFESCIHEALTH
Zobacz inne projekty w ramach tego zaproszenia
System finansowania
NoE - Network of ExcellenceKoordynator
Uczestnicy (176)
FRANKFURT / MAIN
Zobacz na mapie
MUNICH
Zobacz na mapie
BUCHAREST/2
Zobacz na mapie
ROTTERDAM
Zobacz na mapie
GDANSK
Zobacz na mapie
NEWCASTLE UPON TYNE
Zobacz na mapie
BORDEAUX
Zobacz na mapie
ORBASSANO (TO)
Zobacz na mapie
MUNSTER
Zobacz na mapie
CARDIFF (WALES)
Zobacz na mapie
VALENCIA
Zobacz na mapie
BOBINGNY
Zobacz na mapie
HAIFA
Zobacz na mapie
MOSCOW
Zobacz na mapie
BARCELONA
Zobacz na mapie
UTRECHT
Zobacz na mapie
ZAGREB
Zobacz na mapie
WARSAW
Zobacz na mapie
COLOGNE
Zobacz na mapie
COPENHAGEN
Zobacz na mapie
BOURNEMOUTH
Zobacz na mapie
CAEN
Zobacz na mapie
AMSTERDAM
Zobacz na mapie
L'HOSPITALET DE LLOBREGAT
Zobacz na mapie
SHEFFIELD
Zobacz na mapie
NANCY
Zobacz na mapie
TOULOUSE
Zobacz na mapie
GIESSEN
Zobacz na mapie
MODENA
Zobacz na mapie
SALAMANCA
Zobacz na mapie
PARIS
Zobacz na mapie
BUDAPEST
Zobacz na mapie
BRUSSELS
Zobacz na mapie
JERUSALEM
Zobacz na mapie
MUNICH
Zobacz na mapie
HAMBURG
Zobacz na mapie
INNSBRUCK
Zobacz na mapie
ESCHWEILER
Zobacz na mapie
MARSEILLE
Zobacz na mapie
BUDAPEST
Zobacz na mapie
KAISERSLAUTERN
Zobacz na mapie
MILAN
Zobacz na mapie
OLOMOUC
Zobacz na mapie
AG. PARASKEVI, ATTIKIS
Zobacz na mapie
ST. PETERSBURG
Zobacz na mapie
ST. PETERSBURG
Zobacz na mapie
MINSK REGION
Zobacz na mapie
ISTANBUL
Zobacz na mapie
BELFAST
Zobacz na mapie
YEKATERINBURG
Zobacz na mapie
VILLEJUIF
Zobacz na mapie
BELGRADE
Zobacz na mapie
SAMSUN
Zobacz na mapie
RIGA
Zobacz na mapie
LISBON
Zobacz na mapie
BRISTOL
Zobacz na mapie
HERAKLION, CRETE
Zobacz na mapie
MARSEILLE
Zobacz na mapie
LJUBLJANA
Zobacz na mapie
BRATISLAVA
Zobacz na mapie
REGENSBURG
Zobacz na mapie
COIMBRA
Zobacz na mapie
SAINT-PETERSBURG
Zobacz na mapie
LVIV
Zobacz na mapie
NANTES
Zobacz na mapie
TURKU
Zobacz na mapie
ROSTOV-ON-DON
Zobacz na mapie
LYON
Zobacz na mapie